Ontario OTC Drugmaker Warned for Sloppy Lab Work, Testing

Drug Industry Daily
A A
The FDA issued a warning letter to a Concord, Ontario-based over-the-counter drug facility for significant violations of current good manufacturing practices—its third trip through the agency’s ringer.

To View This Article:

Login

Subscribe To Drug Industry Daily